AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34444802 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 404
Study 36202908 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulfate sodium (PPS) monotherapy for 16 weeks
Number of subjects: 26
Study 36202908 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study 33767111 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 127
Study 33767111 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 127
Study 35381230 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable gastroscopes
Number of subjects: 110
Study 35381230 — intervention group
Group type: COMPARATOR
Intervention: Reusable gastroscopes
Number of subjects: 110
Study 34706189 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotrovimab (500 mg single infusion)
Number of subjects: 583
Study 34706189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 583
Study 34706189 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotrovimab
Number of subjects: 583
Study 33382746 — intervention group
Group type: EXPERIMENTAL
Intervention: Da Qing Diabetes Prevention program (DQDP)
Number of subjects: 0
Study 36289063 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 74
Study 36289063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 35133556 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIT-ED treatment (n=94)
Number of subjects: 185
Study 35133556 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (n=91)
Number of subjects: 185
Study 32144803 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate non-occlusal implant loading
Number of subjects: 60
Study 32144803 — intervention group
Group type: COMPARATOR
Intervention: Early non-occlusal implant loading
Number of subjects: 60
Study 34779226 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients fulfilling MR CLEAN criteria
Number of subjects: 2611
Study 34779226 — intervention group
Group type: COMPARATOR
Intervention: Patients not fulfilling MR CLEAN criteria
Number of subjects: 2611
Study 33258358 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 510
Study 33258358 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy
Number of subjects: 510
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person recruitment
Number of subjects: 25
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment at healthcare providers' offices
Number of subjects: 25
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment via mail
Number of subjects: 25
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional study information
Number of subjects: 25
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent calls
Number of subjects: 25
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of flyers at clinics
Number of subjects: 25
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives
Number of subjects: 25
Study 34645442 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal events
Number of subjects: 25
Study 33047689 — intervention group
Group type: EXPERIMENTAL
Intervention: ARFI (Acoustic Radiation Force‐Based Elasticity Imaging)
Number of subjects: 45
Study 34227411 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia website information
Number of subjects: 109
Study 34227411 — intervention group
Group type: COMPARATOR
Intervention: Standard printed information
Number of subjects: 109
Study 32936420 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART-CT index (developed using 7 statistically significant items from CT scans)
Number of subjects: 123
Study 32936420 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART-CT index
Number of subjects: 123
Study 35016914 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg escitalopram
Number of subjects: 71
Study 35016914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 34743631 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D phantom training (Group P)
Number of subjects: 0
Study 34743631 — intervention group
Group type: COMPARATOR
Intervention: Audiovisual lecture only (Group L)
Number of subjects: 0
Study 37086245 — intervention group
Group type: EXPERIMENTAL
Intervention: Istaroxime (0.5 mg/kg/min)
Number of subjects: 26
Study 37086245 — intervention group
Group type: EXPERIMENTAL
Intervention: Istaroxime (1.0 mg/kg/min)
Number of subjects: 26
Study 37086245 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (saline placebo)
Number of subjects: 26
Study 33235342 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic medication with anticoagulants or antihypertensives
Number of subjects: 68
Study 33235342 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up at V2
Number of subjects: 68
Study 35033356 — intervention group
Group type: EXPERIMENTAL
Intervention: IO+IA-PRP (intra-osseous, intra-articular PRP)
Number of subjects: 50
Study 35033356 — intervention group
Group type: COMPARATOR
Intervention: IA-PRP (intra-articular PRP)
Number of subjects: 50
Study 35033356 — intervention group
Group type: EXPERIMENTAL
Intervention: IO+IA-PRP
Number of subjects: 50
Study 35033356 — intervention group
Group type: COMPARATOR
Intervention: IA-PRP
Number of subjects: 50
Study 33653271 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy (COT) - FiO2 of 1.0, 12 L/min
Number of subjects: 150
Study 33653271 — intervention group
Group type: COMPARATOR
Intervention: Normal frequency jet ventilation (NFJV) - FiO2 of 1.0, driving pressure of 0.1 MPa, RR 15 bpm
Number of subjects: 150
Study 33653271 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV) - FiO2 of 1.0, driving pressure of 0.1 MPa, RR 1200 bpm
Number of subjects: 150
Study 36145073 — intervention group
Group type: EXPERIMENTAL
Intervention: FDDB smartphone app and food database
Number of subjects: 10
Study 36145073 — intervention group
Group type: COMPARATOR
Intervention: PRODI® dietary assessment method
Number of subjects: 10
Study 34330770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-acting insulin isophane for postoperative afternoon glucose ≥140 mg/dl
Number of subjects: 263
Study 34330770 — intervention group
Group type: COMPARATOR
Intervention: Short-acting insulin for fasting glucose ≥200 mg/dl (control)
Number of subjects: 263
Study 32610254 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (vitamin C, E, alpha‐lipoic acid)
Number of subjects: 41
Study 32610254 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 41
Study 36066688 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccination information from a man physician-avatar
Number of subjects: 236
Study 36066688 — intervention group
Group type: COMPARATOR
Intervention: HPV vaccination information from a woman physician-avatar
Number of subjects: 236
Study 33938905 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 0
Study 33938905 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 0
Study 36334688 — intervention group
Group type: EXPERIMENTAL
Intervention: VONA-100QD
Number of subjects: 120
Study 36334688 — intervention group
Group type: EXPERIMENTAL
Intervention: VONA-200QD
Number of subjects: 120
Study 36334688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 36334688 — intervention group
Group type: EXPERIMENTAL
Intervention: VONA-100QD and VONA-200QD
Number of subjects: 120
Study 36334688 — intervention group
Group type: EXPERIMENTAL
Intervention: Active arms (VONA-100QD, VONA-200QD)
Number of subjects: 120
Study 33523756 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) injection
Number of subjects: 110
Study 33523756 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA) injection
Number of subjects: 110
Study 32337566 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly Osteopathic Manipulative Treatment (OMT) for 12 consecutive weeks
Number of subjects: 25
Study 32337566 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 25
Study 34338762 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol + Red Bull (RB)
Number of subjects: 16
Study 34338762 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol + RB
Number of subjects: 16
Study 34338762 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Bull (RB)
Number of subjects: 16
Study 34338762 — intervention group
Group type: COMPARATOR
Intervention: Alcohol
Number of subjects: 16
Study 34338762 — intervention group
Group type: COMPARATOR
Intervention: Alcohol + RB placebo
Number of subjects: 16
Study 34338762 — intervention group
Group type: COMPARATOR
Intervention: Both placebos
Number of subjects: 16
Study 34328290 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,565-nm Nonablative Fractional Laser (NAFL)
Number of subjects: 19
Study 34328290 — intervention group
Group type: COMPARATOR
Intervention: 10,600-nm Ablative Fractional Laser (AFL)
Number of subjects: 19
Study 32450106 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (5 × 10^10 viral particles)
Number of subjects: 108
Study 32450106 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle dose (1 × 10^11 viral particles)
Number of subjects: 108
Study 32450106 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (1.5 × 10^11 viral particles)
Number of subjects: 108
Study 32450106 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 108
Study 35296713 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoscopic 360 video and stereoscopic sound environments (natural)
Number of subjects: 60
Study 35296713 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoscopic 360 video and stereoscopic sound environments (urban)
Number of subjects: 60
Study 32090502 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation (arm B)
Number of subjects: 516
Study 32090502 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation plus pharmacological pain management (arm C)
Number of subjects: 516
Study 32090502 — intervention group
Group type: COMPARATOR
Intervention: Control group (arm A)
Number of subjects: 516
Study 34433773 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 94
Study 34433773 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen treatment
Number of subjects: 94
Study 34433773 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 94
Study 34419006 — intervention group
Group type: EXPERIMENTAL
Intervention: Far infrared therapy (FIR) applied to the skin above the AVF three times a week for 1 year
Number of subjects: 0
Study 34419006 — intervention group
Group type: COMPARATOR
Intervention: Control group (observation without treatment)
Number of subjects: 0
Study 34419006 — intervention group
Group type: EXPERIMENTAL
Intervention: Far infrared therapy (FIR)
Number of subjects: 0
Study 32788865 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol (RSV) therapy
Number of subjects: 64
Study 32788865 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 35270504 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated nutrition rehabilitation intervention (parenting classes, shredded fish/liver/anchovy, optimized complementary feeding)
Number of subjects: 480
Study 35270504 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving existing health services
Number of subjects: 480
Study 34499685 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin initiation threshold of ASCVD risk ?7.5%
Number of subjects: 0
Study 34499685 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin initiation threshold of ASCVD risk ?5%
Number of subjects: 0
Study 34499685 — intervention group
Group type: COMPARATOR
Intervention: Statin initiation threshold of ASCVD risk ?10%
Number of subjects: 0
Study 33188960 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Sleeve compression system (SSB)
Number of subjects: 30
Study 33188960 — intervention group
Group type: EXPERIMENTAL
Intervention: Coban 2 (C2)
Number of subjects: 30
Study 33188960 — intervention group
Group type: EXPERIMENTAL
Intervention: Profore Lite (PL)
Number of subjects: 30
Study 32741946 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide plus low-dose dexamethasone therapy
Number of subjects: 0
Study 35565780 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional diet (CD)
Number of subjects: 155
Study 35565780 — intervention group
Group type: EXPERIMENTAL
Intervention: MedDiet-physical activity (MD-PA)
Number of subjects: 155
Study 35565780 — intervention group
Group type: COMPARATOR
Intervention: MedDiet-high meal frequency (MD-HMF)
Number of subjects: 155
Study 34961539 — intervention group
Group type: EXPERIMENTAL
Intervention: gls function
Number of subjects: 0
Study 34961539 — intervention group
Group type: EXPERIMENTAL
Intervention: geese function
Number of subjects: 0
Study 34961539 — intervention group
Group type: EXPERIMENTAL
Intervention: lme function
Number of subjects: 0
Study 34961539 — intervention group
Group type: EXPERIMENTAL
Intervention: lmer function
Number of subjects: 0
Study 34961539 — intervention group
Group type: COMPARATOR
Intervention: All four functions
Number of subjects: 0
Study 36014810 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic formulation (LabinicTM)
Number of subjects: 0
Study 36014810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35421987 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced family planning education using a simplified handout from the WHO FP guidance tool.
Number of subjects: 1004
Study 35421987 — intervention group
Group type: COMPARATOR
Intervention: Routine family planning counselling following Uganda Ministry of Health guidelines.
Number of subjects: 1004
Study 35421987 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced family planning education.
Number of subjects: 1004
Study 35421987 — intervention group
Group type: COMPARATOR
Intervention: Routine family planning counselling.
Number of subjects: 1004
Study 33104835 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular sutures
Number of subjects: 581
Study 33104835 — intervention group
Group type: COMPARATOR
Intervention: Staples
Number of subjects: 581
Study 32168208 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine therapy
Number of subjects: 245
Study 34753814 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg of salbutamol
Number of subjects: 52
Study 34753814 — intervention group
Group type: COMPARATOR
Intervention: Control group (2 mL of nebulized sodium chloride)
Number of subjects: 52
Study 33645864 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% of sensory threshold
Number of subjects: 48
Study 33645864 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% of sensory threshold
Number of subjects: 48
Study 33645864 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory threshold
Number of subjects: 48
Study 32147200 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional support to reach protein and energy goals (n=1015)
Number of subjects: 2028
Study 32147200 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital food (n=1013)
Number of subjects: 2028
Study 32147200 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional support
Number of subjects: 2028
Study 32147200 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional support (full cost analysis)
Number of subjects: 2028
Study 35943099 — intervention group
Group type: EXPERIMENTAL
Intervention: Home blood pressure telemonitoring (HBPM) combined with pharmacist-led case management
Number of subjects: 120
Study 35943099 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care with HBPM alone
Number of subjects: 120
Study 33346926 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department care and support services for opioid use disorder (OUD)
Number of subjects: 24
Study 32125298 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with plant components and bifidobacteria extract
Number of subjects: 40
Study 32125298 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste based on HAP
Number of subjects: 40
Study 35077215 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ultrasound and electrostimulation (CUSECS) with standard wound care treatment twice a week for 8 weeks
Number of subjects: 11
Study 35077215 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care treatment once a week for 8 weeks
Number of subjects: 11
Study 35077215 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ultrasound and electrostimulation (CUSECS)
Number of subjects: 11
Study 35077215 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care treatment
Number of subjects: 11
Study 32847664 — intervention group
Group type: EXPERIMENTAL
Intervention: Child life interventions (CLIs) by a certified child life specialist, two 30‐minute sessions
Number of subjects: 30
Study 36112378 — intervention group
Group type: COMPARATOR
Intervention: Single-dose intravenous antibiotic (cloxacillin 2 g per dose)
Number of subjects: 698
Study 36112378 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose intravenous antibiotic (cloxacillin 2 g per dose over 24 hours)
Number of subjects: 698
Study 36112378 — intervention group
Group type: COMPARATOR
Intervention: Single-dose intravenous antibiotic
Number of subjects: 698
Study 36112378 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose intravenous antibiotic
Number of subjects: 698
Study 33274674 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral feeding
Number of subjects: 132
Study 33274674 — intervention group
Group type: COMPARATOR
Intervention: Control (nil-per-mouth for 5 days and subsequent tube feeding)
Number of subjects: 132
Study 33274674 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 132
Study 35072433 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face preanesthetic interview alone (Group 1)
Number of subjects: 1051
Study 35072433 — intervention group
Group type: EXPERIMENTAL
Intervention: Videos before the interview (Group 2)
Number of subjects: 1051
Study 35072433 — intervention group
Group type: EXPERIMENTAL
Intervention: Brochure before the interview (Group 3)
Number of subjects: 1051
Study 35072433 — intervention group
Group type: EXPERIMENTAL
Intervention: Explanation of different anesthetic techniques by the provider
Number of subjects: 1051
Study 33845640 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-piece inflatable penile prosthesis (IPP) combined with sildenafil
Number of subjects: 123
Study 33845640 — intervention group
Group type: COMPARATOR
Intervention: Three-piece inflatable penile prosthesis (IPP)
Number of subjects: 123
Study 35259681 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) for alcohol harm reduction
Number of subjects: 180
Study 35259681 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) control
Number of subjects: 180
Study 32317001 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 40
Study 32317001 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34854814 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing with a NAO social robot (SR)
Number of subjects: 109
Study 34854814 — intervention group
Group type: COMPARATOR
Intervention: Playing with a study nurse
Number of subjects: 109
Study 34854814 — intervention group
Group type: COMPARATOR
Intervention: Waiting with parents
Number of subjects: 109
Study 32654940 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty (HA)
Number of subjects: 15558
Study 32654940 — intervention group
Group type: COMPARATOR
Intervention: Total hip arthroplasty (THA)
Number of subjects: 15558
Study 33573765 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy food density
Number of subjects: 228
Study 33573765 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential location (urban/rural)
Number of subjects: 228
Study 36127099 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait intervention with minimalist shoes (GIC; n=12)
Number of subjects: 36
Study 36127099 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait intervention in barefoot condition (GID; n=12)
Number of subjects: 36
Study 36127099 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=12)
Number of subjects: 36
Study 34963636 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART (initiation of ART within 2 weeks after randomization)
Number of subjects: 228
Study 34963636 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART (initiation of ART 2 weeks after randomization)
Number of subjects: 228
Study 34963636 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ART
Number of subjects: 228
Study 34963636 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART
Number of subjects: 228
Study 33577050 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 0
Study 33577050 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32212888 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 70
Study 32212888 — intervention group
Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 70
Study 34570315 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) adherence intervention
Number of subjects: 280
Study 34570315 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) adherence during lockdown
Number of subjects: 280
Study 34570315 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecurity
Number of subjects: 280
Study 34570315 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of pandemic impact on ART adherence
Number of subjects: 280
Study 33370161 — intervention group
Group type: EXPERIMENTAL
Intervention: SPARK (Sports, Play and Active Recreation for Kids)
Number of subjects: 60
Study 33370161 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect (exergaming)
Number of subjects: 60
Study 33370161 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 60
Study 35654318 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (AT1R antagonist), single dose
Number of subjects: 59